<DOC>
	<DOCNO>NCT01531530</DOCNO>
	<brief_summary>The purpose study determine whether CVD 1208S ( live , attenuated , oral vaccine ) safe effective prevention Shigella infection .</brief_summary>
	<brief_title>Safety Efficacy Study CVD 1208S , Live , Attenuated Oral Vaccine Prevent Shigella Infection Using cGMP</brief_title>
	<detailed_description>There two purpose conduct Vaccine Study evaluate experimental vaccine call CVD 1208S ( Center Vaccine Development 1208S ) : 1 ) learn whether CVD 1208S cause side effect , 2 ) learn whether CVD 1208S give people immunity Shigella .</detailed_description>
	<mesh_term>Dysentery , Bacillary</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Age 18 45 year , inclusive . Good general health Expressed interest availability fulfill study requirement Informed , write consent . Agrees indefinite storage unused clinical specimen CVD use future research Agrees participate another investigational vaccine drug trial study Has childbearing potential agrees abstain become pregnant day screen ( least 14 day vaccination ) 6 week final vaccination use birth control Agrees donate blood blood bank 12 month receive vaccine . An acute chronic medical condition , opinion investigator , would render vaccination unsafe would interfere evaluation response . Any current illness require daily medication ( vitamin , birth control pill , nasal topical medication , allow ) ; Blood stool &gt; 2 occasion ( small amount strain ) past 12 month ; Recurrent diarrhea ( &gt; 5 episode past 6 month , last 3 day ) . Immunosuppression Long term ( great 2 week ) use oral injected steroid , highdose inhaled steroid ( &gt; 800 micrograms/day beclomethasone dipropionate equivalent ) within precede 6 month ( Nasal topical steroid allow ) . History abdominal surgery Medical , occupational , family problem result alcohol illicit drug use past 12 month . Known allergy intolerance ciprofloxacin , trimethoprim/sulfamethoxazole ( sulfa antibiotic ) , ampicillin ( woman ) corn . History shigellosis Shigella vaccination challenge laboratory worker know exposure Shigella . Anticipates follow first 84 day ( 12 week ) study ( 28 day , 4 week Cohort 1 ) : Shares household child &lt; 3 year age , pregnant woman woman plan become pregnant time ; Household sexual contact someone weaken immunity ( someone HIV infection , someone receive treatment cancer , elderly person &gt; 70 yr ) ; Occupation foodhandler , childcare ( child &lt; 3 year ) , health care worker direct patient contact . A clinically significant abnormality physical examination Results blood test define protocol Positive pregnancy test medical screening within 24 hour inoculation current breast feeding ( woman ) . Failure attain score least 70 % write examination ( two attempt permit ) During past 3 year , develop diarrhea travel develop country , within 1 week return home . Receipt follow : Any vaccine investigational drug within 30 day study vaccine A live , attenuated vaccine within 30 day study vaccine A subunit kill vaccine within 14 day study vaccine A blood product 90 day study vaccine Receipt antibiotic within 7 day inoculation ( within 21 day antibiotic azithromycin ) . Loose stool acute illness fever &gt; 100.0 degree F 48 hour vaccination .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Shigella</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Mucosal immunity</keyword>
</DOC>